Forbes published an article based on Center Scholar Jeffrey Macher’s research on product recalls in the medical technology business.

Posted in News Publications Research  |  Tagged News - Health Services

“Ariel D. Stern, along with Indiana University Assistant Professor George P. Ball and Georgetown University Professor Jeffrey T. Macher, set out to quantify the innovation risks and opportunities that recalls pose in one of the most R&D-intensive industries, medical technology. Product failures in medtech, where the cost to bring a device to the market can top $90 million, can not only hobble a firm, but cause catastrophic harm to patients.”

Read the full article: Why Companies Should Try Harder to Prevent Product Recalls